Literature DB >> 26530672

Quantification of DNA Damage by Real-Time qPCR.

Wei Wang1,2, Katja Scheffler1,2, Ying Esbensen3, Lars Eide4.   

Abstract

This chapter describes the use of real-time qPCR to quantify damages in genomic DNA. The method is based on the ability of a lesion in one strand to inhibit restriction enzyme digestion of double-stranded DNA. Subsequent amplification of the complementary strand after restriction cleavage gives a quantitative measure of the damage content in that site (Real-time qPCR Analysis of Damage Frequency; RADF). We compare the RADF assay with the commonly used technique to assess damages by their ability to inhibit amplification of a large PCR fragment relative to a short PCR fragment. The RADF method described here is quick, accurate and allows the detection of nuclear and mitochondrial DNA damage in detailed regions.

Keywords:  DNA damage; DNA repair; mtDNA

Mesh:

Substances:

Year:  2016        PMID: 26530672     DOI: 10.1007/978-1-4939-3040-1_3

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  9 in total

1.  Simplified qPCR method for detecting excessive mtDNA damage induced by exogenous factors.

Authors:  Artem P Gureev; Ekaterina A Shaforostova; Anatoly A Starkov; Vasily N Popov
Journal:  Toxicology       Date:  2017-03-09       Impact factor: 4.221

Review 2.  Targets for repair: detecting and quantifying DNA damage with fluorescence-based methodologies.

Authors:  Natalie R Gassman; Nathaniel W Holton
Journal:  Curr Opin Biotechnol       Date:  2018-08-13       Impact factor: 9.740

3.  Increased nuclear DNA damage precedes mitochondrial dysfunction in peripheral blood mononuclear cells from Huntington's disease patients.

Authors:  Georgina Askeland; Zaneta Dosoudilova; Marie Rodinova; Jiri Klempir; Irena Liskova; Anna Kuśnierczyk; Magnar Bjørås; Gaute Nesse; Arne Klungland; Hana Hansikova; Lars Eide
Journal:  Sci Rep       Date:  2018-06-29       Impact factor: 4.379

4.  Deterioration of mitochondrial bioenergetics and ultrastructure impairment in skeletal muscle of a transgenic minipig model in the early stages of Huntington's disease.

Authors:  Marie Rodinova; Jana Krizova; Hana Stufkova; Bozena Bohuslavova; Georgina Askeland; Zaneta Dosoudilova; Stefan Juhas; Jana Juhasova; Zdenka Ellederova; Jiri Zeman; Lars Eide; Jan Motlik; Hana Hansikova
Journal:  Dis Model Mech       Date:  2019-07-26       Impact factor: 5.758

5.  The mitochondrial DNA constitution shaping T-cell immunity in patients with rectal cancer at high risk of metastatic progression.

Authors:  P A Bousquet; S Meltzer; A J Fuglestad; T Lüders; Y Esbensen; H V Juul; C Johansen; L G Lyckander; T Bjørnetrø; E M Inderberg; C Kersten; K R Redalen; A H Ree
Journal:  Clin Transl Oncol       Date:  2021-12-27       Impact factor: 3.340

Review 6.  Dynamic features of human mitochondrial DNA maintenance and transcription.

Authors:  Mansour Akbari; Hilde Loge Nilsen; Nicola Pietro Montaldo
Journal:  Front Cell Dev Biol       Date:  2022-09-07

7.  Application of Gamma Ray-Responsive Genes for Transcriptome-Based Phytodosimetry in Rice.

Authors:  Jin-Hong Kim; Kwon Hwangbo; Eujin Lee; Shubham Kumar Dubey; Moon-Soo Chung; Byung-Yeoup Chung; Sungbeom Lee
Journal:  Plants (Basel)       Date:  2021-05-13

8.  A transgenic minipig model of Huntington's disease shows early signs of behavioral and molecular pathologies.

Authors:  Georgina Askeland; Marie Rodinova; Hana Štufková; Zaneta Dosoudilova; Monika Baxa; Petra Smatlikova; Bozena Bohuslavova; Jiri Klempir; The Duong Nguyen; Anna Kuśnierczyk; Magnar Bjørås; Arne Klungland; Hana Hansikova; Zdenka Ellederova; Lars Eide
Journal:  Dis Model Mech       Date:  2018-10-24       Impact factor: 5.758

9.  Markers of Mitochondrial Metabolism in Tumor Hypoxia, Systemic Inflammation, and Adverse Outcome of Rectal Cancer.

Authors:  Paula A Bousquet; Sebastian Meltzer; Linda Sønstevold; Ying Esbensen; Svein Dueland; Kjersti Flatmark; Beathe Sitter; Tone Frost Bathen; Therese Seierstad; Kathrine Røe Redalen; Lars Eide; Anne Hansen Ree
Journal:  Transl Oncol       Date:  2018-09-29       Impact factor: 4.243

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.